Table 4.
Examples of clinical trials with Reolysin.
| Combination | Tumor Type | Phase | Status | Reference |
|---|---|---|---|---|
| Paclitaxel | Ovarian cancer, peritoneal carcinomatosis and cancer of fallopian tube | 2 | Completed | NCT01199263 |
| None | Sarcoma | 2 | Completed | NCT00503295 |
| Carboplatin Paclitaxel |
NSCLC | 2 | Completed | NCT00861627 |
| Irinotecan, Leucovorin, 5-FU, Bevacizumab |
Colorectal cancer | 1 | Completed | NCT01274624 |
| Carboplatin Paclitaxel |
Head and Neck cancer | 3 | Completed | NCT01166542 |
| None | Malignant glioma | 1 | Completed | NCT00528684 |
| Carboplatin Paclitaxel |
Lung Cancer | 2 | Completed | NCT00998192 |
| Carboplatin Paclitaxel |
Head and neck cancer | 2 | Completed | NCT00753038 |
| Carboplatin Paclitaxel |
Metastatic melanoma | 2 | Completed | NCT00984464 |
| Paclitaxel, Avelumab |
Metastatic breast cancer | 2 | Recruiting | NCT04215146 |
| Carfilzomib, Dexamethasone, Nivolumab |
Recurrent Plasma cell myeloma | 1 | Recruiting | NCT03605719 |
| Retifanlimab | TNBC | 2 | Recruiting | NCT04445844 |